These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 39185424)

  • 1. The fate of immune complexes in membranous nephropathy.
    Xu J; Hu H; Sun Y; Zhao Z; Zhang D; Yang L; Lu Q
    Front Immunol; 2024; 15():1441017. PubMed ID: 39185424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology of membranous nephropathy: from animal models to humans.
    Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
    Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is primary membranous nephropathy a complement mediated disease?
    Reinhard L; Stahl RAK; Hoxha E
    Mol Immunol; 2020 Dec; 128():195-204. PubMed ID: 33142137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.
    Zhang P; Huang W; Zheng Q; Tang J; Dong Z; Jiang Y; Liu Y; Liu W
    J Immunol Res; 2021; 2021():8163298. PubMed ID: 34337081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.
    Liu W; Gao C; Dai H; Zheng Y; Dong Z; Gao Y; Liu F; Zhang Z; Liu Z; Liu W; Liu B; Liu Q; Shi J
    Front Immunol; 2019; 10():1809. PubMed ID: 31447839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet challenges in membranous nephropathy.
    Salant DJ
    Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):70-76. PubMed ID: 30451735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.
    Kao L; Lam V; Waldman M; Glassock RJ; Zhu Q
    J Am Soc Nephrol; 2015 Feb; 26(2):291-301. PubMed ID: 25205735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular classification of membranous nephropathy.
    Pozdzik A; Touzani F; Brochériou I; Corazza F
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):336-344. PubMed ID: 31045661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Membranous Nephropathy in the PLA
    Bomback AS
    Clin J Am Soc Nephrol; 2018 May; 13(5):784-786. PubMed ID: 29378770
    [No Abstract]   [Full Text] [Related]  

  • 10. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
    Pozdzik A; Brochériou I; David C; Touzani F; Goujon JM; Wissing KM
    Biomed Res Int; 2018; 2018():6281054. PubMed ID: 29511687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.
    Sethi S; Debiec H; Madden B; Charlesworth MC; Morelle J; Gross L; Ravindran A; Buob D; Jadoul M; Fervenza FC; Ronco P
    Kidney Int; 2020 Jan; 97(1):163-174. PubMed ID: 31901340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
    Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
    Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in membranous nephropathy: success stories of a long journey.
    Ronco P; Debiec H
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):460-6. PubMed ID: 21388432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
    von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
    Front Immunol; 2018; 9():3035. PubMed ID: 30619370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranous nephropathy-one morphologic pattern with different diseases.
    Hoxha E; von Haxthausen F; Wiech T; Stahl RAK
    Pflugers Arch; 2017 Aug; 469(7-8):989-996. PubMed ID: 28555350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
    Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
    Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLA2R and THSD7A: Disparate Paths to the Same Disease?
    Beck LH
    J Am Soc Nephrol; 2017 Sep; 28(9):2579-2589. PubMed ID: 28674044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice.
    Tomas NM; Dehde S; Meyer-Schwesinger C; Huang M; Hermans-Borgmeyer I; Maybaum J; Lucas R; von der Heide JL; Kretz O; Köllner SMS; Seifert L; Huber TB; Zahner G
    Kidney Int; 2023 Feb; 103(2):297-303. PubMed ID: 36191868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating antibodies to α-enolase and phospholipase A
    Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
    Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.
    Ronco P; Debiec H
    Pflugers Arch; 2017 Aug; 469(7-8):997-1005. PubMed ID: 28597189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.